A Multicenter, Adaptive, Randomized, doublE-blinded, Placebo-controlled Study in Participants With Long COVID-19: The REVIVE Trial

Clinical trial NCT06128967 · COMPLETED

Trial details

NCT number: NCT06128967
Sponsor: Cardresearch
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Long COVID-19 Syndrome Chronic Fatigue Syndrome

Start date: 2023-10-18
Primary completion: 2025-07-01
Enrollment: 399

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.